Conjugation of aspirin with vitamin C: Uptake and stability studies

Journal of Drug Delivery Science and Technology

Volumn 19, Issue 1, 2009, Pages 43-50

  Dalpiaz, A ^a   Pavan, B ^b   Strada, M ^a   Biondi, C ^b   Bortolotti, F ^a   Vertuani, S ^a   Ciliberti, N ^a   Manfredini, S ^a  

^a Department of Pharmaceutical Sciences ^*  (Italy)

^b Institute of General Physiology   (Italy)

Author keywords

Aspirin; Blood stability; Human retinal pigment epithelium cells; Kinetics; Plasma stability; Prodrug; SVCT2 transporter; Vitamin C

Indexed keywords

ACETYLSALICYLIC ACID; ASCORBIC ACID; MEMBRANE PROTEIN; SVCT2 TRANSPORTER; UNCLASSIFIED DRUG;

ARTICLE; CELL LABELING; CELLULAR DISTRIBUTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG METABOLISM; DRUG STABILITY; DRUG STRUCTURE; DRUG TRANSPORT; HUMAN; HUMAN CELL; PIGMENT EPITHELIUM; PROTEIN INTERACTION; SOLVENT EFFECT; STRUCTURE ACTIVITY RELATION;

EID: 59849121368     PISSN: 17732247     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1773-2247(09)50006-8     Document Type: Article

References (47)

1. Joseph R., Han, E., Tsering C., Grunfield S., Welch K.M. - Platelet activity and stroke severity - J. Neurol. Sci., 108, 1-6, 1992.
2. Castillo J., Leira R., Moro M.A., Lizasoain I., serena J., Davalos A. - Neuroprotective effects of aspirin in patients with acute cerebral infarction. Neurosci. Lett., 339, 248-250, 2003.
3. Vane J.R. - Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. - Nat. New Biol., 231, 232-235, 1971.
4. Catella Lawson F., Crofford L.J. - Cyclooxygenase inhibition and thrombogenicity - Am. J. Med., 110, S28-S32, 2001.
5. Berger C., Xia F., Schabitz W.R., Schwab S., Grau A. - High-dose aspirin is neuroprotective in a rat focal ischemia model. - Brain Res., 998, 237-242, 2004.
6. Whitehaed S.N., Bayona N.A., Cheng G., Allen G.V., Hachinski V.C., Cecchetto D.F. - Effects of trifIsal and aspirin in a rat model of cerebral ischemia. - Stroke, 38, 381-387, 2007.
7. Grilli M., Pizzi M., Memo M., Spano P. - Neuroprotection by acetyl-salicylic acid and sodium salicylate through blockade of NF-kappa B activation. - Science, 274, 1383-1385, 1996.
8. Khayyam N.,Thavendiranathan P., Carmichael F.J., Kus B., Jay B., Burnham W.M. - Neuroprotective effects of acetylsalicylic acid in an animal model of focal brain ischemia. - Neuroreport, 10, 371-374, 1999.
9. Kontos H.A. - Oxygen radicals in cerebral ischemia: the 2001 Willis lecture. - Stroke, 32, 2712-2716.
10. Kim S.J., Kim Y.K., Takagi G., Huang C.H., Geng Y.J., Vatner S.F. - Enhanced iNOS function in myocytes one day after brief ischemic episode. - Am. J. Physiol. Heart Circ. Physiol., 282, 423-428, 2002.
11. Kuhn W., Müller T., Büttner T., Gerlach M. - Aspirin as free radical scavenger: consequences for therapy of cerebrovascular ischemia. - Stroke, 26, 1959-1960, 1995.
12. De La Cruz J.R, Guerrero A., Gonzalez-Correa J.A., Arrebola M.M., Sanchez de la Cuesta F. - Antioxidant effect of acetylsalicylic and salicylic acid in rat brain slices subjected to hypoxia. - J. Neurosci. Res., 75, 280-290, 2004.
13. De Cristobal J., Moro M.A., Davalos A., Castillo J., Leza J.C., Camarero J., Colado M.I., Lorenzo P., Lizasoain I. - Neuroprotective effect of aspirin by inhibition of glutamate release after permanent focal cerebral ischaemia in rats. - J. Neurochem., 79, 456-459, 2001.
14. De Cristobal J., Cardena A., Lizasoain I. Leza J.C., Fernandez Tomé P., Lorenzo P., Moro M.A. - Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation. - Stroke, 33, 261-267, 2002.
15. De Cristobal J., Madrigal J.L., Lizasoain I., Lorenzo P., Leza J.C., Moro M.A. - Aspirin inhibits stress-induced increase in plasma glutamate, brain oxidative damage and ATP fall in rats. - Neuroreport., 13, 217-221, 2002.
16. Castillo J., Leira R., Moro A.A., Lizosain I., Serena J., Davalos A. - Neuroprotective effects of aspirin in patients with acute cerebral infarction. - Neurosci. Lett., 339, 248-250, 2003.
17. O'Banion M.K., Finch C.E. - Inflammatory mechanism and anti-inflammatory therapy in Alzheimer disease. - Neurobiol. Aging, 17, 669-671, 1996.
18. Hull M., Lieb K., Fiebich B. L. - Anti-inflammatory drugs: a hope for Alzheimer's disease? - Expert Opin. Invest. Drugs, 9, 671-83, 2000.
19. Maharaj D.S., Saravanan, K.S., Maharaj H., Mohanakumar K.P., Daya S. - Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats. - Neurochem. Int., 44, 335-360, 2004.
20. Sasaki T., Ogawa K., Ishii S.I., Senda M. - Synthesis of [11] salycilic acid and related compounds and their distribution in mice. - Appl. Rad. Isot., 50, 905-909, 1999.
21. Meshkinpour H., Hollander D., Harmon D. - Colonic absorption of acetylsalicylic acid in the rat. - Gen. Pharmacol., 15, 55-58, 1984.
22. Kurata J.H., Abbey D.E. - The effect of chronic aspirin use on duodenal and gastric ulcer hospitalisation. - J. Clin. Gastroenterol., 12, 260-266, 1990
23. Velasquez C., Rao P.N., Knaus E.E. - Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies. - J. Med. Chem., 48, 4061-4067, 2005.
24. Nielsen N.M., Bundgaard H. - Evaluation of glycolamide esters and various other esters of aspirin as true aspirin prodrugs. - J. Med. Chem., 32, 727-734, 1989.
25. Gilmer J.F., Moriarty L.M., Lally M.N., Clancy J.M. - Isosorbide-based aspirin prodrugs II. Hydrolysis kinetics of isosorbide diaspirinate. - Eur. J. Pharm. Sci., 16, 297-304, 2002.
26. Gilmer J.F, Moriarty L., Clancy J.M. - Evaluation of nitrate-substituted pseudocholine esters of aspirin as potential nitro-aspirins. - Biorg. Med. Chem. Lett., 17, 3217-3220, 2007.
27. Whitehouse M.W., Rainsford K.D. - Esterification of acidic anti-inflammatory drugs suppresses their gastrotoxicity without adversely affecting their anti-inflammatory activity in rats. - J. Pharm. Pharmacol., 32, 795-796, 1980.
28. Ammar H.O., Ghorab M., El-Nahas S.A., Kamel R. - Design of a transdermal delivery system for aspirin as an antithrombotic drug. - Int. J. Pharm., 327, 81-88, 2006.
29. Manfredini S., Pavan B., Vertuani S., Scaglianti M., Compagnone D., Biondi C., Scatturin A., Tanganelli S., Ferraro L., Prasad P.D. Dalpiaz, A. - Design, synthesis and activity of ascorbic acid prodrugs of nipecotic, kynurenic and diclophenamic acids, liable to increase neurotropic activity. - J. Med. Chem., 45, 559-562, 2002.
30. Manfredini S., Vertuani S., Pavan, B, Vitali F., Scaglianti M., Bortolotti F., Biondi C., Scatturin A., Prasad P. Dalpiaz A. - Design, synthesis and in vitro evaluation on HRPE cells of ascorbic and 6-bromoascorbic acid conjugates with neuroactive molecules. - Biorg. Med. Chem., 12, 5453-5463, 2004.
31. Dalpiaz A., Pavan B., Vertuani S., Vitali F., Scaglianti M., Bortolotti F., Biondi C., Scatturin A., Tanganelli S., Ferraro L., Marzola G., Prasad P., Manfredini S. - Ascorbic and 6-Br-ascorbic acid conjugates as a tool to increase the therapeutic effects of potentially central active drugs. - Eur. J. Pharm., 24, 259-269, 2005.
32. Dalpiaz A., Pavan B., Scaglianti M., Vitali F., Bortolotti F., Biondi C., Scatturin, A.,Tanganelli, S., Ferraro, L., Prasad, P., Manfredini, S. - Transporter-mediated effects of diclofenamic acid and its ascorbyl pro-drug in the in vivo neurotropic activity of ascorbyl nipecotic acid conjugate. - J. Pharm. Sci., 93, 78-85, 2004.
33. Dalpiaz A., Pavan B., Scaglianti M., Vitali F., Bortolotti F., Biondi C., Scatturin A., Manfredini S. - Vitamin C and 6-amino-vitamin C conjugates of diclofenac: synthesis and evaluation. - Int. J. Pharm., 291, 171-181, 2005.
34. +-dependent L-ascorbic acid transporters. - Nature, 399, 70-75, 1999.
35. Toimela T., Mäenpää H., Mannerström M. Tähti, H. - Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminium. - Toxicol. Appl. Pharmacol., 195, 73-82, 2004.
36. Rajan D.P., Huang W., Dutta B., Devoe L.D., Leibach F.H., Ganapathy V., Prasad P.D. - Human placental sodium-dependent vitamin C transporter (SVCT2): molecular cloning and trasport function. - Biochem. Biophys. - Res. Comm., 262, 762-768, 1999.
37. Kato K., Terao S., Shimamoto N., Hirata M. - Studies on scavengers of active oxygen species. 1. Synthesis and biological activityof 2-O-alkylascorbic acids. - J. Med.Chem., 31, 793-798, 1988.
38. Del Monte M.A., Maumenee I.H. - In vitro culture of human retinal pigment epithelium for biochemical and metabolic study. - Vision Res., 21, 137-142, 1981.
39. Dutt K., Waldrep J.C., Kaplan H.J., Del Monte, M. Semple, E. Verly, G. - In vitro phenotypic and functional characterization of human pigment epithelial cell lines. - Curr. Eye Res., 8, 435-440, 1989.
40. Washko P., Rotrosen D., Levine, M. - Ascorbic acid transport and accumulation in human neutrophils. - J. Biol. Chem., 264, 18996-19002, 1989.
41. Biondi C., Pavan B., Dalpiaz A., Medici S., Lunghi L., Vesce F. - Expression and characterization of vitamin C transporter in the human trophoblast cell line HTR-8/SVneo: effect of steroids, flavonoids and NSAIDs. - Mol. Hum. Reprod., 13, 77-83, 2007.
42. Rumsey S.C., Welch R.W., Garraffo H.M., Ge P., Lu S.F., Crossman A.T., Kirk K.L., Levine M. - Specificity of ascorbate analogs for ascorbate transport. - J. Biol. Chem., 274, 23215-23222, 1999.
43. Dalpiaz A., Filosa R., de Caprariis P., Conte G., Bortolotti F., Biondi C., Scatturin A., Prasad P.D. and Pavan B. - Molecular mechanism involved in the transport of a prodrug dopamine glycosyl conjugate. - Int. J. Pharm., 336, 133-139, 2007.
44. Masson P., Froment M.T., Fortier P.L., Visicchio J.E., Bartels C.F., Lockridge O. - Butyrylcholinesterase-catalysed hydrolysis of aspirin, a negatively charged ester, and aspirin-related neutral esters. - Biochim. Biophys. Acta, 1387, 41-52, 1998.
45. Bakar S.K., Niazi S. - Stability of aspirin in diffeent media. - J. Pharm. Sci., 72, 1024-1026, 1983.
46. Sarmento B., Ribeiro A., Veiga F., Sampaio P. Neufeld R., Ferriera D. - Alginate/chitosan nanoparticles are effective for oral insulin delivery. - Pharm. Res., 24, 2198-2206, 2007.
47. Bravo-Osuna I., Vauthier C., Chacun H., Ponchel G. - Specific permeability modulation of intestinal paracellular pathway by chitosan-poly(isobutylcyanoacrylate)core-shell nanoparticles. - Eur. J. Pharm. Biopharm., 69, 436-444, 2008.